In HbS/S patients with sickle cell anemia (SCA), there are two peaks, one representing HbS and the other Hb-Voxelotor fraction, the latter having similar mobility as native HbD in HPLC assays. This evidence concerns the gene GSTM1 and sickle cell disease.